Early home discharge in low-risk PE patients, as identified by validated triage tools (sPESI and Hestia), is safe with very low incidences of adverse events and mortality. However, patients with cancer, elevated troponin, or elevated NT-proBNP have a higher risk of adverse events and may require closer monitoring.
Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis | European Heart Journal | Oxford Academic (oup.com)